Bristol-Myers Squibb Company operates in the biopharmaceutical sector, focusing on the discovery, development, and delivery of medicines for various diseases. Its primary therapeutic areas include oncology, hematology, neuroscience, immunology, and cardiovascular diseases. The company develops treatments aimed at addressing unmet medical needs and has a pipeline of compounds in various stages of development across multiple disease areas.
